Abstract:Objective This study aimed to analyze the clinical effect of simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy (HIPEC) on synchronous colorectal cancer liver metastasis. Methods 144 patients with synchronous colorectal cancer liver metastasis who were admitted to our hospital from January 2018 to January 2019 were randomly assigned into a control group and an intervention group. The patients in the control group received simultaneous resection of liver metastases. The patients in the intervention group obtained simultaneous resection of liver metastases combined with HIPEC. The recent total effective rate of the two groups was compared, and the disease control rate of the two groups was calculated at 3 months after treatment. The patients were followed up for 3 years. The survival time of the two groups was observed and compared. Fasting venous blood was collected from patients in the two groups, and the carcinoembryonic antigen (CEA) level was compared. The level of quality of life scale (SF-36) and the occurrence of adverse reactions were compared between the two groups. Results The R0 complete resection rate in the intervention group was significantly higher than that in the control group (P < 0.05). The recent total effective rate in the intervention group (87.50%) was significantly higher than that in the control group (59.72%) (P < 0.05). The negative change of CEA in the intervention group was 72.22%, which was prominently higher than that in the control group of 43.06% (χ 2 =12.542, P<0.001). Following a 36-month follow-up, the overall survival rate of the observation group was significantly higher than that of the control group [HR=2.54(1.05~5.48), P<0.001]. The patients in the intervention group had significantly higher life quality scores of health status, social function, emotional function, physical function, and mental health than the control group (P < 0.05). There was no significant difference in the incidence of complications between the two groups (P > 0.05). Age > 60 years, preoperative comorbidities, moderate and high differentiation of tumors, intraoperative blood loss > 150ml and less experienced surgeons were risk factors affecting the occurrence of complications after treatment, and were closely correlated with the prognosis and survival of patients (P < 0.05). Patients with age ≤ 60 years, no preoperative comorbidities, low tumor differentiation, intraoperative blood loss ≤ 150ml, more experienced surgeons and complete R0 resection had a longer survival time. Age > 60 years, preoperative comorbidities, moderate and high differentiation of tumors, intraoperative blood loss > 150ml and less experienced surgeons were independent risk factors affecting the prognosis of patients with colorectal cancer liver metastases (P < 0.05), while R0 surgery was an independent protective factor for the prognosis (P < 0.05). Conclusion In the treatment of synchronous colorectal cancer liver metastases, simultaneous resection of liver metastases in conjunction with HIPEC demonstrated superior efficacy. This approach may potentially extend patient survival and enhance quality of life, and deserve to be extensively used in clinical practice.

[The Effects of Combined Hepatectomy and Immuno-Chemotherapy on Postoperative Recurrence Rate of Primary Liver Cancer].

Evaluation of the Curative Effect of Transcatheter Arterial Chemoembolization Via Hepatic Artery Combined with Percutaneous Ethanol Injection for the Treatment of Primary Hepatocellular Carcinoma

Short-Term Effect Of Combined Therapy With Jinlong Capsule ((Sic)) And Transcatheter Arterial Chemoembolization On Patients With Primary Hepatic Carcinoma And Its Influence On Serum Osteopontin Expression

Preoperative Combined with Postoperative Chemoembolization Can Improve Survival in Patients with Hepatocellular Carcinoma: A Single-center Study

Systemic Chemotherapy Improves Outcome of Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

Effect of Hepatectomy Combined with Splenectomy on Patients of Primary Hepatocellular Carcinoma with Hypersplenism

Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis

Salvage Surgery after Combination Immunotherapy for Initially Unresectable or Metastastic Hepatocellular Carcinoma: A Retrospective Clinical Study

Hepatic Histopathology and Postoperative Outcome after Preoperative Chemotherapy for Chinese Patients with Colorectal Liver Metastases.

Post-transplant Infection Improves Outcome of Hepatocellular Carcinoma Patients after Orthotopic Liver Transplantation.

The effect of transcatheter arterial chemoembolization combined with ultrasound-guided radiofrequency ablation on the efficacy and immune function in patients with primary liver cancer

Effect of Radiofrequency Ablation with Interventional Therapy of Hepatic Artery on the Recurrence of Primary Liver Cancer and the Analysis of Influencing Factors

Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma

Early Intrahepatic Recurrence of Hepatocellular Carcinoma after Hepatectomy Treated with Re-Hepatectomy, Ablation or Chemoembolization: a Prospective Cohort Study.

Postoperative adjuvant immunotherapy and molecular targeted therapy for patients of hepatocellular carcinoma with portal vein tumor thrombus after hepatectomy: a propensity score matching study

The Safety and Therapeutic Effect Analysis of Intraoperative Intraperitoneal Chemotherapy with Lobaplatin for Hepato-Biliary-Pancreatic Cancer

Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.

Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis

The Clinical Value of the Hepatic Lobectomy Combined with Radical Resection for Perihilar Cholangiocarcinoma

A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma.